Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel BVDV-2 mutants as new candidates for modified-live vaccines.

Veterinary microbiology - 21 Apr 2010

Zemke Johanna, König Patricia, Mischkale Katrin, Reimann Ilona, Beer Martin

Abstract excerpt

Protection against Bovine viral diarrhea virus (BVDV) type 2 infection of commercially available vaccines is often limited due to marked genetic and antigenic differences between BVDV types 1 (BVDV-1) and 2 (BVDV-2). Therefore, the immunogenicity of selected BVDV-1 and BVDV-2 mutants derived from infectious full-length cDNA clones and their use as modified-live vaccine candidates against challenge infection with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Body Temperature
Share to Cattle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukocytes

Share to Viral Envelope Proteins

Share to Viral Load

Share to Viral Vaccines

Source

Identifiers

PMID: 19875253
DOI: 10.1016/j.vetmic.2009.09.045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel BVDV-2 mutants as new candidates for modified-live vaccines.PMID 19875253Read ↗

Assessment of the clinical and virological protection provided by a commercial inactivated bovine viral diarrhoea virus genotype 1 vaccine against a BVDV genotype 2 challenge.Semantic proximity Read ↗

Characterisation of a new infectious full-length cDNA clone of BVDV genotype 2 and generation of virus mutants.Semantic proximity Read ↗

Bovine viral diarrhea virus with deletions in the 5'-nontranslated region: reduction of replication in calves and induction of protective immunity.Semantic proximity Read ↗

Rapid Generation of Replication-Deficient Monovalent and Multivalent Vaccines for Bluetongue Virus: Protection against Virulent Virus Challenge in Cattle and SheepSemantic proximity Read ↗

Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge.Semantic proximity Read ↗

Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus VaccinesSemantic proximity Read ↗

Generation of Replication-Defective Virus-Based Vaccines That Confer Full Protection in Sheep against Virulent Bluetongue Virus ChallengeSemantic proximity Read ↗

A Synthetic Biology Approach for a Vaccine Platform against Known and Newly Emerging Serotypes of Bluetongue VirusSemantic proximity Read ↗

Recombinant Bovine Herpesvirus Type I Expressing the Bovine Viral Diarrhea Virus E2 Protein Could Effectively Prevent Infection by Two VirusesSemantic proximity Read ↗

Efficacy of a new multivalent vaccine for the control of bovine respiratory disease (BRD) in commercial fattening unitsSemantic proximity Read ↗

Cross-Neutralization between Bovine Viral Diarrhea Virus (BVDV) Types 1 and 2 after Vaccination with a BVDV-1a Modified-Live-VaccineSemantic proximity Read ↗

Impact of species and subgenotypes of bovine viral diarrhea virus on control by vaccination.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.